Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$573K Buy
4,461
+10
+0.2% +$1.17K 0.19% 46
2026
Q1
$535K Buy
4,451
+12
+0.3% +$1.39K 0.19% 48
2025
Q4
$467K Sell
4,439
-88
-2% -$8.26K 0.17% 59
2025
Q3
$380K Sell
4,527
-97
-2% -$7.99K 0.13% 71
2025
Q2
$366K Sell
4,624
-559
-11% -$44.4K 0.13% 68
2025
Q1
$465K Buy
5,183
+387
+8% +$36.1K 0.18% 53
2024
Q4
$477K Buy
4,796
+9
+0.2% +$928 0.17% 55
2024
Q3
$544K Sell
4,787
-1,836
-28% -$218K 0.23% 48
2024
Q2
$820K Buy
6,623
+208
+3% +$26.8K 0.36% 35
2024
Q1
$846K Sell
6,415
-356
-5% -$43.9K 0.59% 32
2023
Q4
$738K Sell
6,771
-1,125
-14% -$117K 0.56% 35
2023
Q3
$813K Sell
7,896
-968
-11% -$104K 0.59% 31
2023
Q2
$1.02M Buy
8,864
+3,480
+65% +$395K 0.75% 22
2023
Q1
$573K Buy
5,384
+12
+0.2% +$1.3K 0.54% 30
2022
Q4
$596K Buy
5,372
+16
+0.3% +$1.64K 0.52% 31
2022
Q3
$461K Buy
5,356
+14
+0.3% +$1.25K 0.42% 36
2022
Q2
$487K Buy
5,342
+16
+0.3% +$1.42K 0.41% 41
2022
Q1
$437K Buy
5,326
+78
+1% +$6.15K 0.3% 53
2021
Q4
$393K Buy
5,248
+15
+0.3% +$1.2K 0.26% 53
2021
Q3
$393K Hold
5,233
0.27% 53
2021
Q2
$408K Sell
5,233
-1,424
-21% -$106K 0.31% 54
2021
Q1
$484K Buy
6,657
+18
+0.3% +$1.33K 0.4% 43
2020
Q4
$475K Buy
+6,639
New +$508K 0.41% 42

Other funds holding MRK

Clarus Group's MRK Position: Q2 2026 in Review

Clarus Group increased its Merck (MRK) stake by 0.22% in Q2 2026, buying an estimated $1.17K and bringing the position to 4,461 shares worth $573K. The position accounts for 0.19% of the portfolio, ranked #46.

Clarus Group first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.02M in Q2 2023. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Clarus Group held 4,461 shares of Merck worth $573K as of Q2 2026.
  • Clarus Group bought 10 Merck shares in Q2 2026, an estimated $1.17K.
  • Merck made up 0.19% of Clarus Group's portfolio in Q2 2026, its #46 holding.
  • Clarus Group first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • Clarus Group's Merck position peaked at $1.02M in Q2 2023.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Clarus Group's 13F filing for Q2 2026, filed 24 Jul 2026.